Detected ·
Pathos
$237MSeries E
Pathos AI has closed a $237 million Series E, led by Bristol Myers Squibb at a ~$3B post-money valuation, to scale its agentic AI drug development platform Foundry and advance its oncology pipeline.
- Website
- —
- linkedin.com/company/81971915
- Amount
- $237 000 000 USD
- Stage
- Series E
- Event
- Funding round
- Detected
- 2026-10-25 16:01:36 UTC
- Signal ID
- 28a1d62e-9709-4566-84eb-76d0a5aacb5a
As the API returns it
{
"id": "28a1d62e-9709-4566-84eb-76d0a5aacb5a",
"created_at": "2026-10-25T16:01:36.705256Z",
"company_name": "Pathos",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/81971915",
"event_type": "funding",
"funding_amount": 237000000,
"funding_currency": "USD",
"funding_stage": "series_e",
"message": "*Pathos AI has closed a $237 million Series E, led by Bristol Myers Squibb at a ~$3B post-money valuation, to scale its agentic AI drug development platform Foundry and advance its oncology pipeline.*"
}